Abiopharma

Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025

Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December

Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference

Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek®

UroGen Pharma to Present at Guggenheim Securities Healthcare Innovation Conference

Calidi Biotherapeutics Announces Investor Event to be Held on Friday, November 7th at the 2025 SITC Annual Meeting

DocGo Announces Upcoming Launch of Longitudinal Care Services for Major California Health Plan

BridgeBio to Participate in November Investor Conferences

Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference

Actinium Pharmaceuticals, Inc. to Highlight ATNM-400 Data in Hormone-Resistant and HER2-Resistant Breast Cancer at the 2025 San Antonio Breast Cancer Symposium, Expanding Pan-Tumor Profile Across Three Solid Tumor Indications